Eurofins Advinus

Executive Summary

Eurofins Advinus is a leading preclinical CRO and CDMO based in Bangalore, India, offering comprehensive drug discovery, toxicology, safety assessment, DMPK, and process chemistry services for small molecules. With over 30 years of GLP-compliant experience, the company supports global regulatory submissions across pharmaceuticals, agrochemicals, nutraceuticals, and cosmetics. Its integrated platform and cost-competitive positioning in India make it attractive for biopharma outsourcing. The company serves a diverse client base from virtual biotechs to large pharma, leveraging Eurofins' global network for expanded reach. As drug development becomes more complex, Eurofins Advinus is well-positioned to capture demand for reliable, high-quality preclinical services.

Upcoming Catalysts (preview)

• Q3 2026Major contract win with a top-20 pharma for long-term toxicology studies60% success
• Q4 2026Expansion into biologics testing services (e.g., biosimilar characterization)40% success
• Q2 2026Completion of new state-of-the-art facility for GLP in vivo studies, increasing capacity by 30%70% success